Cellectis S.A. was founded in 1999 and is headquartered in Paris, France. It is a clinical-stage biopharmaceutical company, focused on developing and marketing genetically-edited T-cell- based immuno-oncology products for treating leukemia patients. The company also develops innovative plant-based products... Show More
The idea of CopyPortolio (i.e @CRISPR-Tech) is very good and useful in terms of diversification. It is somewhat similar to an ETF, that is to say, investing in a basket or collection of securities that often tracks an underlying index.
I view it also as similar to a closed- and / or open-ended mutual... Show More